Product image of Medipekt (Bromhexine Hydrochloride) supplied by GNH India

Medipekt

Active Ingredient:
Bromhexine Hydrochloride
Origin:
EU

Medipekt (Bromhexine Hydrochloride)

Bromhexine Hydrochloride, the active ingredient in Medipekt, is a mucolytic presented as an oral tablet for oral use. It helps to loosen and clear thick bronchial mucus in patients with acute or chronic respiratory conditions.

GNH India supplies Medipekt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Orion Corporation

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Medipekt, a mucolytic, is indicated for disorders of the respiratory tract where mucus clearance is impaired.

  • Acute bronchitis: reduces mucus viscosity to ease productive cough.
  • Chronic bronchitis: facilitates expectoration and improves airway patency.
  • Chronic obstructive pulmonary disease (COPD): aids clearance of bronchial secretions during exacerbations.
  • Productive cough associated with respiratory tract infections: promotes sputum removal and symptom relief.

How It Works

  • Bromhexine hydrochloride increases the activity of ciliary cells in the respiratory epithelium and breaks down mucopolysaccharide fibers, thereby lowering mucus viscosity. The combined effect enhances mucociliary transport, allowing faster clearance of bronchial secretions and improving airway ventilation.

Side Effects

Bromhexine Hydrochloride may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Nausea: mild stomach upset occurring after oral intake.
  • Vomiting: occasional expulsion of stomach contents.
  • Abdominal discomfort: transient pain or cramping.
  • Diarrhoea: loose stools that resolve with continued therapy.
  • Taste disturbances: altered or metallic taste.
  • Skin rash: mild erythematous eruption.

Serious or Rare Side Effects

  • Allergic reactions: including angioedema or anaphylaxis.
  • Severe skin reactions: such as Stevens‑Johnson syndrome.
  • Hepatotoxicity: abnormal liver function tests.
  • Blood dyscrasias: rare cases of neutropenia or eosinophilia.
  • Bronchospasm: paradoxical tightening of airways.
  • Persistent vomiting: may lead to dehydration.

Precautions & Warnings

When using Medipekt, consider the following precautions to ensure safe and effective therapy.

  • Pregnancy: safety not established; use only if clearly needed.
  • Breastfeeding: unknown safety; weigh benefits against potential risks.
  • Renal impairment: monitor renal function as the drug is excreted renally.
  • Asthma: may provoke bronchospasm; observe respiratory status.
  • Duplicate mucolytic therapy: avoid concomitant use of other expectorants.
  • Store at below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Bromhexine Hydrochloride can interact with other medicines; awareness of key interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Anticholinergic agents: may reduce mucolytic effect.
  • Codeine‑containing cough suppressants: counteract expectorant action.
  • Strong anticholinergic bronchodilators: potential reduction in therapeutic benefit.

Moderate Interactions (Monitor Closely)

  • Macrolide antibiotics: may increase gastrointestinal irritation.
  • Antihistamines: possible enhancement of sedation.
  • Alcohol: can exacerbate gastrointestinal side effects.

Frequently Asked Questions

Medipekt is an over‑the‑counter mucolytic indicated for the relief of productive cough associated with acute bronchitis, chronic bronchitis, chronic obstructive pulmonary disease (COPD) and other respiratory tract infections where thick mucus hampers breathing.

Bromhexine hydrochloride enhances the activity of ciliary cells and breaks down the glycoprotein structure of mucus, reducing its viscosity. This facilitates faster mucociliary clearance, helping patients expectorate sputum more easily.

The dosage of Medipekt is determined by the prescribing healthcare professional based on the patient’s age, condition severity and renal function. Patients should follow the prescriber’s instructions and the product label.

Safety data for bromhexine hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and under medical supervision.

To order Medipekt, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both bromhexine and acetylcysteine act as mucolytics, but bromhexine primarily enhances ciliary activity and reduces mucus viscosity, whereas acetylcysteine breaks disulfide bonds in mucus proteins. Clinical choice depends on patient tolerance, specific respiratory condition and physician preference.

Medipekt should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiry date.

Medipekt is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the dosing schedule prescribed by their healthcare provider.

Serious adverse reactions, although rare, include allergic responses such as angioedema or anaphylaxis, severe skin reactions like Stevens‑Johnson syndrome, hepatotoxicity, blood dyscrasias, and bronchospasm. Any signs of these conditions require immediate medical attention.

Medipekt should be avoided in individuals with known hypersensitivity to bromhexine or any excipients, in patients experiencing active bronchospasm, and in those for whom duplicate mucolytic therapy is unnecessary. Caution is advised in pregnant or breastfeeding women and patients with severe renal impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Bromhexine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT